Evelo Biosciences, Inc. IPO Research Information

Evelo Biosciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Evelo Biosciences, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Evelo Biosciences, Inc.	EVLO - NASDAQ	$15.00-$17.00	$16.00	$16.00	5.3 million	5/9/2018
Underwriter(s): Morgan Stanley, Cowen, BMO Capital Markets
Co-Manager(s): JMP Securities
Industry: Health Care
Filing(s): Filed 2018-04-13 Terms Added 2018-04-30 Final Prospectus 2018-05-09

Evelo Biosciences, Inc. Quote & Chart - Click for current quote - EVLO

About Evelo Biosciences, Inc. (adapted from Evelo Biosciences, Inc. prospectus):
Evelo Biosciences is discovering and developing potential therapies designed to act on the gut-body network.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EVLO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.